TRACK D - Medical Device & Digital Health:
Pain Management: Changing the Landscape
Pain management is plaguing communities across the country. Long-term solutions for combating this crisis will depend upon biomedical innovation and the development of novel and safer next generation therapies to treat both pain and addiction. To get these new innovations to the patients whose lives depend on them we must ensure that the policy and regulatory environment keeps pace with the advances happening in the lab. A patient-centric approach to the treatment of pain and addiction will help prevent and provide better care for those who are diagnosed with addiction. Panelists will discuss the barriers and solutions around current coverage and reimbursement policies to ensure patient access to resources for pain and addiction treatment.
Susan Kushins, MBA
Senior Director of Strategy & Portfolio Management, Respiratory, Gastrointestinal & Informatics, Medtronic
Susan Kushins is the Senior Director of Strategy & Portfolio Management for the $2.5B Respiratory, Gastrointestinal, and Informatics business unit of Medtronic. She is responsible for developing long-range objectives to achieve long-term sustainable growth partnering with three division and commercial regions. Susan and her team help to value internal R&D innovations and anticipate market disruption partnering closely with Business Development & Licensing to balance organic and inorganic investments.
Susan has had over a 20-year, cross-functional career in healthcare spanning production, marketing, sales, and strategy working in both small and large organizations. In her 10-year career in medical devices, Susan has extensive experience in accelerating the adoption of disruptive technologies through market development. The opportunity assessment and sizing efforts Susan led at Given Imaging was foundational to secure a 5x multiple with the sale to Covidien (now Medtronic) for $1 billion in 2014.
Susan received her B.S. in Industrial Engineering from Georgia Tech, M.S. in Systems Engineering from Steven’s Tech, and MBA from University of North Carolina. She currently resides in Johns Creek, GA with her husband Stephen and children, Samantha and Sebastian. In her spare time, Susan enjoys yoga, hiking, and watersports with her family.
Amy Baxter, MD
CEO & Chief Medical Officer, Pain Care Labs
Pediatric emergency physician and pain researcher Amy Baxter MD founded Pain Care Labs in 2006 with the mission to eliminate unnecessary pain. She invented and patented VibraCool® Vibrational Cryotherapy to treat tendinopathies and decrease opioid use; her disruptive Buzzy® device has been used to control needle pain for over 32 million needle procedures. Her Oscillice™ technology is proven in 30+ RCTs, and was named "Industry Leader in Noninvasive Pain relief" by Frost & Sullivan.
Dr. Baxter funded her neuromodulation pain-reduction platform with SBIR NIH grants. She has received 8 patents, and novel FDA 510K indications for treating muscle and injection pain.
Speaking venues include GIST Venturewell, Exponential Medicine, Bloomberg, Converge, AARP Life at 50+, TEDx and TEDMED. She has been named a Healthcare Gamechanger, Healthcare Transformer, Wall Street Journal “Idea Person”, Most Innovative CEO of the Year by GA Bio, a Top 10 Disruptors in Medical Tech, and “Top Women in Tech to Watch” by Inc. She is also known for turning down Mark Cuban, Robert Herjavec, and Mr. Wonderful on Shark Tank.
Arik Hananel, MD, MBA, BsCs
CEO & Co-Founder, FUS Mobile
Dr. Hananel notable former positions include Scientific and Medical Director of the Focused Ultrasound Foundation, InSightec management member, Co-chief executive editor of journal of therapeutic ultrasound, UVA faculty and ISTU board member.
Dr. Hananel authored multiple publications in peer reviewed journals, presentations in academic and industry conferences and patents.
Craig Steinman, MBA
Associate Director, Global Strategic Marketing, Avanos Medical
Craig Steinman is an Associate Director, Global Strategic Marketing for Avanos Medicals. In his current role Craig is responsible for commercial strategy for all new organic or inorganic products in the Interventional Pain space. Prior to joining Avanos Medical Craig’s career included over 25 years of experience in medical marketing, strategy and new product planning in diverse therapeutic areas in the pharmaceutical market with G.D. Searle and Abbott Molecular Diagnostics. Mr. Steinman has been involved in bringing multiple innovative products to market including the hypnotic Ambien. Mr. Steinman has a BS in Biochemistry from the University of Missouri-Columbia and an MBA from Maryville University.